Oxymetazoline Hydrochloride Spray.

Functions and indications:
Oxymetazoline hydrochloride spray: used for children aged 2-6 years with acute and chronic rhinitis, sinusitis, allergic rhinitis, and hypertrophic rhinitis. Oxymetazoline hydrochloride nasal drops: used for acute and chronic rhinitis, sinusitis, allergic rhinitis, and hypertrophic rhinitis. Oxymetazoline hydrochloride eye drops: used to relieve the eye symptoms of allergic conjunctivitis and non-infectious conjunctivitis, and relieve eye congestion caused by factors such as allergies, dry eyes, swimming, smog, wearing contact lenses (invisible lenses), and eye fatigue.
Usage and dosage:
The dosage and usage of this product may vary depending on the dosage form and specifications. Please read the specific drug instructions for use, or follow the doctor’s advice. Oxymetazoline hydrochloride spray: nasal spray. For adults and children over 6 years old, 1-3 sprays on one side at a time, once in the morning and before bedtime. Oxymetazoline hydrochloride eye drops: eye drops. 1-2 drops each time, once every 8 hours. Oxymetazoline hydrochloride nasal drops: nasal drops. Adults and children over 6 years old, 1-3 drops on one side at a time, once in the morning and once in the evening.
Adverse reactions:
Oxymetazoline hydrochloride spray, oxymetazoline hydrochloride nasal drops: 1. Frequent use of the drug can easily cause rebound nasal congestion, and long-term use can cause drug-induced rhinitis. 2. A few people have mild burning sensations, tingling sensations, dry nasal mucosa, headaches, dizziness, and increased heart rate. 3. Rare allergic reactions. Oxymetazoline hydrochloride eye drops: It may cause mydriasis and increase intraocular pressure in some allergic patients. There have been no reports of systemic reactions caused by local absorption of this product.
Contraindications:
Oxymetazoline hydrochloride spray, oxymetazoline hydrochloride nasal drops: 1. It is contraindicated for patients with atrophic rhinitis and dry nasal cavity. 2. It is contraindicated for pregnant women and children under 2 years old. 3. Patients who are receiving monoamine oxidase inhibitors (such as pargyline, phenelzine, doxetine)